UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Choosing the right index fund in retirement can impact outcomes. This overview compares Sp 500 vs Total Market to help you decide with clarity.
28,517 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Nokia is quietly positioning itself as a top infrastructure play in AI networking, challenging Cisco's dominance with...
Imagine an AI that studies your crypto habits during idle moments and preps the next move you might take. This articl...
In 1999, Mark Cuban reportedly earned more from hedging Yahoo shares with a protective collar than from selling Broad...
At midyear 2026, JPMorgan’s top three overweight picks show a split: one stock has cleared its upside target, while t...
The 2008 crisis left more than scars. Its real legacy 2008: moral hazard and policy backstops still push risk, pricin...
Palantir has cooled off after a blazing run, but analysts say there's still meaningful upside. This guide breaks down...
Alphabet and Meta delivered divergent Q4 results, underscoring different paths to durable profits. Cloud, AI, and cap...
As 2026 unfolds, Tesla and BYD are diverging on growth bets. This article weighs earnings, margins, and software stra...
A fresh wave of Monday analyst notes drives action in tech, travel, and fintech names, with AppLovin and CrowdStrike ...
As accel acel 2025 earnings loom, investors seek clarity on revenue, margins, and guidance. This guide breaks down wh...
Lucid delivered higher volumes and nudged toward improving efficiency, signaling a potential turn in its long EV jour...